Literature DB >> 12637545

Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest.

Linan Ha1, Susan Ceryak, Steven R Patierno.   

Abstract

The ataxia telangiectasia mutated (ATM) protein plays a central role in early stages of DNA double strand break (DSB) detection and controls cellular responses to this damage. Although hypersensitive to ionizing radiation-induced clonogenic lethality, ataxia telangiectasia cells are paradoxically deficient in their ability to undergo ionizing radiation-induced apoptosis. This contradiction illustrates the complexity of the central role of ATM in DNA damage response and the need for further understanding. Certain hexavalent chromium (Cr(VI)) compounds are implicated as occupational respiratory carcinogens at doses that are both genotoxic and cytotoxic. Cr(VI) induces a broad spectrum of DNA damage, but Cr(VI)-induced DSBs have not been reported. Here, we examined the role of ATM in the cellular response to Cr(VI) and found that Cr(VI) activates ATM. We also show that physiological targets of ATM, p53 Ser-15 and Chk2 Thr-68, were phosphorylated by Cr(VI) exposure in an ATM-dependent fashion. We found that ATM-/- cells were markedly resistant to Cr(VI)-induced apoptosis but considerably more sensitive to Cr(VI)-induced clonogenic lethality than wild type cells, indicating that resistance to Cr(VI)-induced apoptosis did not confer a selective survival advantage. However, analysis of long term growth arrest revealed a striking difference: ATM-/- cells were markedly less able to recover from Cr(VI)-induced growth arrest. This indicates that terminal growth arrest is the fate of these apoptosis-resistant cells. In summary, ATM is involved in cellular response to a complex genotoxin that may not directly induce DSBs. Our data suggest that ATM is a major signal initiator for genotoxin-induced apoptosis but, paradoxically, also contributes to maintenance of cell survival by facilitating recovery/escape from terminal growth arrest. The results also strongly suggest that terminal growth arrest is not merely an extended or even irreversible form of checkpoint arrest, but instead an independent and unique cell fate pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637545     DOI: 10.1074/jbc.M210560200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest.

Authors:  Jian Xu; Francis C R Manning; Travis J O'Brien; Susan Ceryak; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

Review 2.  Chromium genotoxicity: A double-edged sword.

Authors:  Kristen P Nickens; Steven R Patierno; Susan Ceryak
Journal:  Chem Biol Interact       Date:  2010-04-27       Impact factor: 5.192

3.  Mismatch repair proteins are activators of toxic responses to chromium-DNA damage.

Authors:  Elizabeth Peterson-Roth; Mindy Reynolds; George Quievryn; Anatoly Zhitkovich
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

4.  p53-Dependent but ATM-independent inhibition of DNA synthesis and G2 arrest in cadmium-treated human fibroblasts.

Authors:  Feng Cao; Tong Zhou; Dennis Simpson; Yingchun Zhou; Jayne Boyer; Bo Chen; Taiyi Jin; Marila Cordeiro-Stone; William Kaufmann
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-11       Impact factor: 4.219

5.  FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.

Authors:  Susan K Vilcheck; Susan Ceryak; Travis J O'Brien; Steven R Patierno
Journal:  Mutat Res       Date:  2006-08-08       Impact factor: 2.433

6.  Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: a possible model for early stage carcinogenesis.

Authors:  Kristen P Nickens; Ying Han; Harini Shandilya; Ashley Larrimore; Gary F Gerard; Eric Kaldjian; Steven R Patierno; Susan Ceryak
Journal:  Biochim Biophys Acta       Date:  2011-10-25

7.  Chromium disrupts chromatin organization and CTCF access to its cognate sites in promoters of differentially expressed genes.

Authors:  Andrew VonHandorf; Francisco Javier Sánchez-Martín; Jacek Biesiada; Hongxia Zhang; Xiang Zhang; Mario Medvedovic; Alvaro Puga
Journal:  Epigenetics       Date:  2018-05-03       Impact factor: 4.528

8.  Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice.

Authors:  Yunxia Fan; Jerald L Ovesen; Alvaro Puga
Journal:  J Trace Elem Med Biol       Date:  2012-05-19       Impact factor: 3.849

9.  Polo-like kinase 1 enhances survival and mutagenesis after genotoxic stress in normal cells through cell cycle checkpoint bypass.

Authors:  Gina Chun; Dongsoon Bae; Kristen Nickens; Travis J O'Brien; Steven R Patierno; Susan Ceryak
Journal:  Carcinogenesis       Date:  2010-01-20       Impact factor: 4.944

10.  Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK.

Authors:  Susan Ceryak; Carla Zingariello; Travis O'Brien; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.